JP2001072684A5 - - Google Patents

Download PDF

Info

Publication number
JP2001072684A5
JP2001072684A5 JP2000289527A JP2000289527A JP2001072684A5 JP 2001072684 A5 JP2001072684 A5 JP 2001072684A5 JP 2000289527 A JP2000289527 A JP 2000289527A JP 2000289527 A JP2000289527 A JP 2000289527A JP 2001072684 A5 JP2001072684 A5 JP 2001072684A5
Authority
JP
Japan
Prior art keywords
benzothieno
alkyl
formula
benzodiazepine
methylpiperazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000289527A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001072684A (ja
JP4354106B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2000289527A priority Critical patent/JP4354106B2/ja
Priority claimed from JP2000289527A external-priority patent/JP4354106B2/ja
Publication of JP2001072684A publication Critical patent/JP2001072684A/ja
Publication of JP2001072684A5 publication Critical patent/JP2001072684A5/ja
Application granted granted Critical
Publication of JP4354106B2 publication Critical patent/JP4354106B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000289527A 1997-09-02 2000-09-22 縮合チオフェン化合物およびその医薬用途 Expired - Fee Related JP4354106B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000289527A JP4354106B2 (ja) 1997-09-02 2000-09-22 縮合チオフェン化合物およびその医薬用途

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP23670097 1997-09-02
JP9-236700 1997-09-02
JP27777197 1997-10-09
JP9-277771 1997-10-09
JP10-165725 1998-06-12
JP16572598 1998-06-12
JP2000289527A JP4354106B2 (ja) 1997-09-02 2000-09-22 縮合チオフェン化合物およびその医薬用途

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP51595799A Division JP3156933B2 (ja) 1997-09-02 1998-08-31 縮合チオフェン化合物およびその医薬用途

Publications (3)

Publication Number Publication Date
JP2001072684A JP2001072684A (ja) 2001-03-21
JP2001072684A5 true JP2001072684A5 (cg-RX-API-DMAC7.html) 2009-02-05
JP4354106B2 JP4354106B2 (ja) 2009-10-28

Family

ID=27322564

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51595799A Expired - Fee Related JP3156933B2 (ja) 1997-09-02 1998-08-31 縮合チオフェン化合物およびその医薬用途
JP2000289527A Expired - Fee Related JP4354106B2 (ja) 1997-09-02 2000-09-22 縮合チオフェン化合物およびその医薬用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP51595799A Expired - Fee Related JP3156933B2 (ja) 1997-09-02 1998-08-31 縮合チオフェン化合物およびその医薬用途

Country Status (16)

Country Link
US (2) US6271225B1 (cg-RX-API-DMAC7.html)
EP (1) EP1016664B1 (cg-RX-API-DMAC7.html)
JP (2) JP3156933B2 (cg-RX-API-DMAC7.html)
KR (1) KR20010021989A (cg-RX-API-DMAC7.html)
CN (1) CN1268949A (cg-RX-API-DMAC7.html)
AT (1) ATE244245T1 (cg-RX-API-DMAC7.html)
AU (1) AU739385B2 (cg-RX-API-DMAC7.html)
BR (1) BR9814042A (cg-RX-API-DMAC7.html)
CA (1) CA2302409A1 (cg-RX-API-DMAC7.html)
DE (1) DE69816102D1 (cg-RX-API-DMAC7.html)
HU (1) HUP0003718A3 (cg-RX-API-DMAC7.html)
IL (1) IL134812A0 (cg-RX-API-DMAC7.html)
NO (1) NO20001049L (cg-RX-API-DMAC7.html)
NZ (1) NZ503484A (cg-RX-API-DMAC7.html)
RU (1) RU2197491C2 (cg-RX-API-DMAC7.html)
WO (1) WO1999011647A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US6751036B2 (en) * 2000-08-04 2004-06-15 Seagate Technology Llc Tuning track density for data storage device
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
EP2363396A1 (en) * 2001-06-11 2011-09-07 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
ES2285227T3 (es) 2002-08-05 2007-11-16 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina.
DE60332482D1 (de) 2002-12-10 2010-06-17 Virochem Pharma Inc Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
US20040236181A1 (en) * 2003-04-01 2004-11-25 Olympus Corporation In-body information acquiring apparatus and power-supply circuit
CA2536107A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
RU2248205C1 (ru) * 2003-09-18 2005-03-20 Открытое акционерное общество "Щелковский витаминный завод" Лекарственное средство в виде желатиновой капсулы
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
WO2005063771A1 (en) * 2003-12-22 2005-07-14 Teva Pharmaceutical Industries Ltd Methods of preparing olanzapine
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof
SG176488A1 (en) * 2006-11-15 2011-12-29 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections
PL395468A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
JP6551671B2 (ja) * 2015-08-11 2019-07-31 国立大学法人 熊本大学 アルツハイマー治療薬
US12365696B2 (en) 2019-05-10 2025-07-22 Dana-Farber Cancer Institute, Inc. Small-molecule focal adhesion kinase (FAK) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
CH468400A (de) 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3683084A (en) 1969-02-06 1972-08-08 Jean Schmutz Basically substituted heterocycles as anti-emetics
US3726977A (en) 1969-02-06 1973-04-10 Sandoz Ag 2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4115568A (en) 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
US4172831A (en) 1974-11-26 1979-10-30 Lilly Industries Limited Thieno-benzodiazepines
GB1533236A (en) * 1975-11-24 1978-11-22 Lilly Industries Ltd Thieno(1,5)benzodiazepine intermediates
US4157444A (en) 1978-03-13 1979-06-05 American Cyanamid Company 10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5538965A (en) 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
US5602121A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
US5700445A (en) 1994-12-12 1997-12-23 Allelix Biopharmaceuticals, Inc. N-methyl piperazine compounds having dopamine receptor affinity
US5602124A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5576314A (en) 1994-12-12 1996-11-19 Allelix Biopharmaceuticals Inc. Bicyclic nonane and decane compounds having dopamine receptor affinity
US5602120A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Benzyl-substituted compounds having dopamine receptor affinity
US5561127A (en) 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands

Similar Documents

Publication Publication Date Title
RU2000108433A (ru) Конденсированные производные тиофена и их фармацевтическое применение
AU776077B2 (en) Use of CRF antagonists and related compositions
US9428506B2 (en) Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
JP2010523556A5 (cg-RX-API-DMAC7.html)
CA3095101A1 (en) Deuterated octahydro-quinoxaline derivatives and pharmaceutical compositions thereof use in the treatment of diseases involving serotonin 5-ht2a, dopamine d1/d2 and/or serotonin reuptake transporter (sert) pathways
RU2007121768A (ru) Би- и трициклически замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1 (glyt-1) для лечения болезни альцгеймера
EP3897621A1 (en) Organic compounds
JP2014514349A5 (cg-RX-API-DMAC7.html)
BR112018069594B1 (pt) Compostos orgânicos, composição farmacêutica compreendendo os ditos compostos e uso dos mesmos para o tratamento ou profilaxia de um distúrbio do sistema nervoso central
RU2000110738A (ru) Бициклические ингибиторы киназ
CA2474219A1 (en) Dihydrobenzodiazepin-2-one derivatives iii
EP2968320A1 (en) Organic compounds
EP1718311A1 (en) Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
RU2001105536A (ru) Производные аминометилкарбоновой кислоты
HRP20140151T1 (hr) Derivati spiro-indola za lijeäśenje parazitnih bolesti
JP2008517913A5 (cg-RX-API-DMAC7.html)
RU2005135338A (ru) Замещенные 3-цианотиофенацетамиды в качестве антагонистов рецептора глюкагона
EP1657242A4 (en) imidazopyridine
MXPA03011638A (es) Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
NZ503294A (en) Halogen substituted tetracyclic tetrahydrofuran derivatives and pharmaceutical use
RU2005122924A (ru) Производные тетрагидрохинолина
WO2001027110A3 (de) Am sechsring substituierte, bicyclische imidazo-3-yl-aminderivate
KR930002320A (ko) 8-비닐-및 8-에티닐-퀴놀론-카르복실산
EP0434695A1 (en) Method of treating neurological disorders
IE68524B1 (en) Novel pyrido[2,3-f] [1,4]thiazepines and pyrido [3,2-b] [1,5]benzothiazepines